Expanding treatment strategies for hepatocellular carcinoma patients: postoperative adjuvant transarterial chemoembolization

In spite of the recent improvements in diagnostic and treatment options for hepatocellular carcinoma (HCC) patients, with an increasing number of patients diagnosed in early stage and offered more effective therapies, the high recurrence rates even after radical treatments, such as surgery or radiofrequency ablation, still represent an unsolved issue (1).